FDAnews
www.fdanews.com/articles/158703-the-church-in-wales-under-scrutiny-over-big-pharma-investment

The Church in Wales Under Scrutiny Over Big Pharma Investment

September 16, 2013
The Church in Wales has invested approximately $9.5 million in GlaxoSmithKline, $8 million in AstraZeneca, $6 million into Novartis and $4 million into Pfizer — investments some critics call unethical.
Blue & Green Tomorrow